Tau Therapeutics, LLC Completes Phase 1 Clinical Trial of Mibefradil for Use in Oncology
1/3/2013 9:13:25 AM
More...
|
Tau Therapeutics, LLC Closes $3 Million Financing to Support Cancer Trial
12/18/2012 9:01:16 AM
More...
|
Tau Therapeutics, LLC to Address World Drug Repositioning Congress
9/11/2012 9:58:02 AM
More...
|
Tau Therapeutics, LLC and National Cancer Institute Launch Phase Ib Clinical Trial in Brain Cancer
5/31/2012 10:02:41 AM
More...
|
Tau Therapeutics, LLC to Present Posters at American Association for Cancer Research on T-Type Calcium Channel Inhibitors and Interlaced Therapy
3/29/2012 7:02:06 AM
More...
|
Tau Therapeutics, LLC IND Accepted by FDA for Novel Cancer Drug
2/28/2012 10:51:27 AM
More...
|